US Patent Issued to Board of Regents, The University of Texas System on Nov. 11 for "Compounds and methods for the treatment of PKR-associated diseases" (Texas Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,610, issued on Nov. 11, was assigned to Board of Regents, The University of Texas System (Austin, Texas).

"Compounds and methods for the treatment of PKR-associated diseases" was invented by Apar Pataer (Houston), Bulent Ozpolat (Houston), Stephen G. Swisher (Houston) and Ruping Shao (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are RNA-dependent protein kinase (PKR)-associated compounds for the treatment of PKR-associated disorders including cancer, neurodegenerative diseases, and inflammatory conditions."

The patent was filed on Feb. 7, 2020, under Application No. 17/429,301.

*For further information, including images, ...